(PRO Views are unique to PRO subscribers, giving them perception on the information of the day direct from a actual investing professional. See the complete dialogue above.) New York Stock Exchange insider Jay Wood pointed to rising momentum in Pfizer and two different beaten-down shares that he believes professional traders ought to watch forward of their upcoming quarterly outcomes. As markets sit within the lull interval between the last earnings season and the subsequent, the chief market strategist at Freedom Capital Markets known as out Pfizer as a title might proceed to achieve as traders look to the ultimate quarter of the 12 months. “Pfizer, talk about a turnaround … health care, pharma stocks starting to turn around because of that news last week. Let’s see if that momentum can continue,” Woods mentioned. “When you’re looking at levels in Pfizer, watch $29 — another two more points to go. If you break above that, it breaks out of a nice neutral base and could go into $35 over the coming six to eight weeks. The pharmaceutical giant are now up more than 1.5% for the year after its 15.2% rally last week. The move was sparked by Pfizer’s deal with the Trump administration to receive a three-year exemption to tariffs in exchange for its commitment to invest in domestic manufacturing and agreement to lower U.S. drug prices for Medicaid patients. PFE 1Y mountain Pfizer stock performance over the past year. Woods is also watching Delta Air Lines and PepsiCo ahead of their earnings Thursday before the bell, particularly because the stocks could present a buying opportunity in un-loved parts of the market. “Transports have been lagging. Delta, consider it or not, it is down [3%] for the 12 months. For the last three quarters, it was up 9%, up 23%, up 12% after earnings. So it has reacted positively, however it will possibly by no means hold that momentum going,” Woods said about the airline company. “Let’s see what that information is in Delta, and see if you happen to lastly get again to the plus aspect for the 12 months.” PepsiCo, meanwhile, is down more than 7% this year but could report results that push the stock past a key resistance level, according to Woods. “Staples have been hammered all 12 months. … If we are able to get again above $146, it could be on a highway to restoration and get that inventory constructive for the 12 months,” Woods said about the beverage giant, which traded around $140 on Monday. What else Woods is watching this week: Traders have shrugged off the U.S. government shutdown, with the S & P 500 looking to build on its most recent all-time highs in the start of the new trading week From the Fed: Federal Reserve minutes out Wednesday at 2 p.m. ET and commentary from Vice Chair Michelle Bowman, Governor Stephen Miran and Minneapolis Fed President Neel Kashkari expected this week Economic data: Consumer sentiment due Friday at 10 a.m. ET “might give us an concept of what the buyer is pondering, however once more, should not move the needle.” Market movers: OpenAI’s deal with Advanced Micro Devices that could give OpenAI a 10% stake in the chipmaker ; Fifth Third Bancorp’s acquisition of Comerica for $10.9 billion is “a constructive tailwind” (This weekly Monday video is exclusively for CNBC PRO subscribers.)